Latest Ubiquitin Stories
NEW YORK, July 16, 2014 /PRNewswire-USNewswire/ -- Alzheimer's disease affects approximately 5.2 million people in the United States alone, and it is the nation's sixth leading cause of death.
Brenda Schulman, Ph.D., joins an illustrious group of scientists recognized by the academy. Memphis, Tenn.
Scientist's 'monumental' discoveries underlie one of the largest fields in modern biomedical research, including efforts to treat cancer and neurodegenerative diseases ALBANY, N.Y.,
A new chemical messenger that is critical in protecting the brain against Parkinson's disease has been identified by scientists at the Medical Research Council (MRC) Protein Phosphorylation and Ubiquitylation Unit at the University of Dundee.
Disruptive clumps of mutated protein are often blamed for clogging cells and interfering with brain function in patients with the neurodegenerative diseases known as spinocerebellar ataxias.
Histone Methyltransferases: Global Markets for Research Tools, Diagnostics and Drug Discovery, increased R&D spending in the development of epigenetic tools and assays for Histone Methyltransferases
Reportbuyer.com just published a new market research report:
According to a new technical market research report, the global ubiquitin proteasome research and development market was valued at nearly $2.9 billion in 2013.
- Sleep; the state or condition of being asleep.